EcoDrugPlus

Macrophage-Stimulating Protein Receptor-Like

Ensembl ID : ENSPNAG00000007895
Gene Symbol: LOC108424117
2 Cross references
188 Possible Orthologues:

Mannan-Binding Lectin Serine Protease 2-Like

Ensembl ID : ENSPNAG00000020600
Gene Symbol: LOC108429007
2 Cross references
176 Possible Orthologues:

Mast/stem Cell Growth Factor Receptor Kita-Like

Ensembl ID : ENSPNAG00000007877
Gene Symbol: LOC108434356
3 Cross references
200 Possible Orthologues:

Matrix Metallopeptidase 1

Ensembl ID : ENSPNAG00000028859
Gene Symbol: MMP1
3 Cross references
288 Possible Orthologues:

Matrix Metallopeptidase 1

Ensembl ID : ENSPNAG00000028112
Gene Symbol: MMP1
4 Cross references
286 Possible Orthologues:

Matrix Metallopeptidase 1

Ensembl ID : ENSPNAG00000028037
Gene Symbol: MMP1
3 Cross references
287 Possible Orthologues:

Matrix Metallopeptidase 14

Ensembl ID : ENSPNAG00000005852
Gene Symbol: MMP14
3 Cross references
198 Possible Orthologues:

Matrix Metallopeptidase 2

Ensembl ID : ENSPNAG00000006306
Gene Symbol: MMP2
3 Cross references
209 Possible Orthologues:

Matrix Metallopeptidase 9

Ensembl ID : ENSPNAG00000004141
Gene Symbol: MMP9
1 Cross references
215 Possible Orthologues:

Matrix Metalloproteinase-14-Like

Ensembl ID : ENSPNAG00000021519
Gene Symbol: LOC108438939
3 Cross references
196 Possible Orthologues:

Matrix Metalloproteinase-18-Like

Ensembl ID : ENSPNAG00000027971
Gene Symbol: LOC108433242
2 Cross references
194 Possible Orthologues:

Matrix Metalloproteinase-20-Like

Ensembl ID : ENSPNAG00000008802
Gene Symbol: LOC108425790
2 Cross references
164 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).